Cargando…
Small-Molecule Targeting of RNA Polymerase I Activates a Conserved Transcription Elongation Checkpoint
Inhibition of RNA polymerase I (Pol I) is a promising strategy for modern cancer therapy. BMH-21 is a first-in-class small molecule that inhibits Pol I transcription and induces degradation of the enzyme, but how this exceptional response is enforced is not known. Here, we define key elements requis...
Autores principales: | Wei, Ting, Najmi, Saman M., Liu, Hester, Peltonen, Karita, Kucerova, Alena, Schneider, David A., Laiho, Marikki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016085/ https://www.ncbi.nlm.nih.gov/pubmed/29642000 http://dx.doi.org/10.1016/j.celrep.2018.03.066 |
Ejemplares similares
-
The small-molecule BMH-21 directly inhibits transcription elongation and DNA occupancy of RNA polymerase I in vivo and in vitro
por: Jacobs, Ruth Q., et al.
Publicado: (2021) -
DNA intercalator BMH-21 inhibits RNA polymerase I independent of DNA damage response
por: Colis, Laureen, et al.
Publicado: (2014) -
Expression of RNA polymerase I catalytic core is influenced by RPA12
por: Ford, Brittany L., et al.
Publicado: (2023) -
Design, Synthesis, and Structure–Activity
Relationships
of Pyridoquinazolinecarboxamides as RNA Polymerase I Inhibitors
por: Colis, Laureen, et al.
Publicado: (2014) -
Regulation of RNA Polymerase I Stability and Function
por: Pitts, Stephanie, et al.
Publicado: (2022)